Nekroza potkožnog masnog tkiva kod dojenčeta by Olgica Milankov et al.
231
Subcutaneous fat necrosis of the infant
Olgica Milankov1, Radojica Savić1, Milena Bjelica2, Dragan Katanić1, 
† Jovan Lovrenski3, † Nada Vučković4
Subcutaneous fat necrosis of the newborn and infant is a rare disease, with still unknown incidence, which usually occurs in term or 
post-term newborns that have experienced perinatal stress. It usually occurs within the fi rst six weeks of newborn’s life; however, 
onset of the disease may be delayed for several months. A 6-week-old female infant was admitted to our department due to failure 
to thrive, irritability and vomiting. Physical examination in the area of the inner thighs, hips, back and shoulders, revealed the 
presence of subcutaneous infi ltrations, which were fi rm, slightly livid, and did not seem painful to touch. Laboratory analysis showed 
hypercalcemia, ultrasonographic review of body fat revealed hyperechogenicity, while abdominal ultrasound revealed nephrocalci-
nosis. Computerized tomography detected the presence of calcifi cations in the brain. Deep skin biopsy confi rmed the diagnosis of 
subcutaneous fat necrosis. Treatment included fl uid loading, termination of vitamin D substitution, and low calcium diet. Single 
doses of calcitonin and pamidronate were administered. After this therapy, calcium levels returned to normal range. Subcutaneous 
infi ltrates gradually decreased and became softer. In most reported cases, regression of skin lesions is expected after a few months, 
often without any residue on the skin. Elevated serum calcium may persist long after the withdrawal of cutaneous lesions, which is 
the reason for continuous monitoring of serum calcium and appropriate treatment in case of hypercalcemia in order to prevent 
metastatic calcifi cation.
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INTRODUCTION
Subcutaneous fat necrosis (SFN) of the newborn is a rare 
disease, with still unknown incidence, which usually occurs 
in term or post-term newborns that have experienced peri-
natal stress in the form of asphyxia, meconium aspiration, or 
hypothermia. Gender and race have no eff ect on the onset 
of the disease (1-4). It usually occurs within the fi rst six weeks 
of life; however, the onset of the disease may be delayed for 
several months. The precise pathophysiology of this disease 
is still unknown. It is believed that stress in the neonatal pe-
riod, followed by hypoperfusion of the skin and hypother-
mia, with still insuffi  ciently developed enzyme system, leads 
to an inability to desaturate saturated fatty acids, which 
causes crystallization, necrosis and the granulomatous in-
fl ammatory reaction in adipocytes. This is clinically mani-
fested by the appearance of fi rm, erythematous plaques 
and nodes, predominantly localized on the trunk, arms, 
thighs, gluteal region and cheeks (5-9). These lesions are 
usually painless (1). Patients are usually afebrile and in good 
general condition. The disease is self-limiting and transient, 
and in most cases there is spontaneous restitution of skin 
lesions and no specifi c therapy is required. However, in 
some cases, the disease may lead to hypercalcemia, a com-
plication usually occurring several weeks after the appear-
ance of skin lesions. Associated hypercalcemia can lead to 
signifi cant morbidity (calcifi cation of tissues, irritability, 
vomiting, hypotonia, constipation, failure to thrive, seizures, 
blindness), and even death. In such instances, therapy 
should be geared towards lowering serum calcium. Since 
hypercalcemia may be present for some time following 
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withdrawal of cutaneous lesions, periodical monitoring of 
serum calcium is needed in these children (8, 12). Besides 
hypercalcemia, hypertriglyceridemia, thrombocytopenia, 
anemia and hypoglycemia may also be found in SFN (10).
CASE REPORT
A 6-week-old female infant was admitted to our depart-
ment due to failure to thrive, irritability and vomiting. She 
was born at term, by vaginal delivery, pelvic presentation, 
with foul-smelling meconium in amniotic fl uid. There was a 
delay in the expulsion of the child. Body weight at birth was 
3270 g, body length 53 cm, head circumference 33 cm, Ap-
gar score 1/3/5 (1’, 5’, 10’). After birth, the child was hospital-
ized at the Clinical Department of Pediatrics due to meco-
nium aspiration syndrome and subarachnoid hemorrhage 
complicated with neonatal sepsis. During hospital stay, she 
had neonatal jaundice and hypoglycemia, and was diag-
nosed with ventricular septal defect. She was released after 
four weeks of hospital stay in good general condition. After 
discharge from the hospital, at home, she refused meals, 
was tearful, irritable and slept insuffi  ciently, with occasional 
vomiting, and after two weeks, at the age of 6 weeks, the 
child was readmitted to our Department.
On admission, she was alert, hypotonic and irritable, afe-
brile, with respirations of 40 per minute and heart rate 132 
per minute, hypotrophic (body weight 2920 g, length 53 
cm, head circumference 34 cm, all under the 5th percentile). 
Physical examination in the area of the inner thighs, hips, 
back and shoulders, revealed the presence of subcutaneous 
infi ltrations, which were fi rm, slightly livid, and did not seem 
painful to touch. There were also signs of dehydration 
(sunken fontanel, shriveled and dry skin, dry and sticky 
mouth). There was second/third degree systolic murmur 
over the precordium (punctum maximum over the Erb’s 
point).
Laboratory analysis showed hypercalcemia of 3.04 mmol/L, 
high urinary calcium/creatinine ratio, anemia, hypertriglyc-
eridemia, low HDL cholesterol, elevated AST, gamma GT 
and LDH with signifi cantly lower levels of PTH (<2.5 pg/mL), 
while vitamin D was within the normal range. Ultrasono-
graphic review and computerized tomography of body fat 
revealed hyperechogenicity (Figures 1 and 2), while ab-
dominal ultrasound revealed nephrocalcinosis. Computer-
ized tomography detected the presence of calcifi cations in 
the brain. Electromyoneurography fi ndings were normal. 
Karyotype was normal, 46,XX. Biopsies of subcutaneous 
adipose tissue confi rmed the diagnosis of SFN. The subcu-
taneous adipose tissue contained necrotic fat tissue infi l-
trated with multinucleated giant cells with numerous cho-
lesterol crystals, needle-shape clefts and mixed infl amma-
tory infi ltrate. The infl ammatory infi ltrate was present in the 
entire lobules, however, more prominent in the peripheral 
parts of the lobules (Figure 3).
FIGURE 1. Computed tomography: 
hyperdensity in the gluteal region.
FIGURE 2. Necrosis of subcutaneous fat tissue, presented as extremely 
increased echogenicity of subcutaneous fat on ultrasonography
FIGURE 3. Histopathologic fi ndings: focal necrosis of subcutaneous fat 
tissue with multinucleated giant cells with numerous cholesterol 
crystals and mixed infl ammatory infi ltrate (HE, X200). 
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Treatment included fl uid loading, termination of vitamin D 
substitution, and low calcium diet. Single dose of calcitonin 
was administered. Despite this therapy, the serum calcium 
levels were still at the upper limit. Therefore, the patient was 
given one dose of bisphosphonates (pamidronate, 2 mg/kg 
in i.v. infusion). After this therapy, calcium levels returned to 
the normal range. During hospitalization, the child’s general 
condition was good, with satisfactory gain weight. Subcuta-
neous infi ltrates gradually decreased and became softer. 
The child was discharged after two months of hospital stay 
with normal calcium values and complete regression of 
subcutaneous changes.
DISCUSSION
Subcutaneous fat necrosis is a rare disorder that is associat-
ed with perinatal complications such as asphyxia, hypother-
mia, meconium aspiration, a primary defect in the subcuta-
neous tissue, as well as preeclampsia and gestational diabe-
tes. It is obvious that neonatal stress has an important role in 
initiating necrotic processes in adipose tissue (1, 13). This 
was the case in our patient as well, who had severe asphyx-
ia and meconium aspiration.
This disorder occurs more frequently in children born at 
term, as well as in post-term neonates (5, 13), as seen in our 
patient. The appearance of skin lesions generally occurs 
within the fi rst six weeks of life (10). Our patient was diag-
nosed with skin lesions at the age of six weeks, with no in-
formation available on their possible earlier existence. Le-
sions occurred on the interior part of the thigh, the left and 
right hip, back, and in the shoulder area, which corresponds 
to the predilection sites described in the literature. These 
lesions are usually solid erythematous nodules, without an 
increase in local temperature. Pain is present in 25% of cases 
and is caused by the existing infl ammation (1). In the case of 
our patient, subcutaneous nodules were slightly livid, were 
not warm, but were fi rm to touch and did not seem pain-
ful.
The diagnosis of SFN usually requires deep skin biopsy, since 
it may be diffi  cult to exclude sclerema neonatorum, which 
carries a mortality rate of 75%, while the prognosis of SFN is 
good (2). In most reported cases, regression of skin lesions is 
expected after a few months, often without any residue on 
the skin (5, 7, 8), which proved to be the case in our patient. 
In some patients, drainage of necrotic tissue through the 
skin may occur, as well as the formation of scars or skin atro-
phy (1). If there are no associated complications, these chil-
dren are usually in good general condition and afebrile. The 
most frequent complication of SFN is hypercalcemia. It usu-
ally occurs a few weeks after the onset of the disease, lead-
ing to various disorders and even death of the patient (4, 8). 
The cause of the occurrence of hypercalcemia is thought to 
be increased bone resorption (due to the eff ect of prostag-
landin E), the release of calcium from necrotic cells and, for 
the most part, unregulated extrarenal production of calci-
triol by macrophages of granulomatous infi ltrates (5, 8, 9). 
Hypercalcemia can often cause calcifi cation of tissues and 
organs (8, 10), as seen in our patient. It is the most frequent 
and dangerous complication of SFN because of its potential 
lethal eff ects on cardiovascular and renal systems. Therapy 
is focused on the elimination of excessive calcium and vita-
min D intake, and adequate hydration with intravenous nor-
mal saline. Furosemide may be helpful to induce calciuresis, 
but has to be used carefully in order to avoid dehydration 
and consequent worsening of hypercalcemia. Corticoster-
oids, calcitonin, citrate and bisphosphonates may be re-
quired as second-line therapy in resistant cases (10, 15). 
Hypertriglyceridemia and anemia may also occur, as well as 
thrombocytopenia and hypoglycemia (8, 10, 14). 
CONCLUSION
Regression of skin lesions is expected after a few months, 
often without any residue on the skin. Elevated serum cal-
cium may persist long after withdrawal of cutaneous le-
sions, which is the reason for continuous monitoring of se-
rum calcium and appropriate treatment in case of hypercal-
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S A Ž E T A K
Nekroza potkožnog masnog tkiva kod dojenčeta
Olgica Milankov, Radojica Savić, Milena Bjelica, Dragan Katanić, † Jovan Lovrenski, † Nada Vučković
Nekroza potkožnog masnog tkiva kod novorođenčeta i dojenčeta je rijetka bolest još uvijek nepoznate incidencije, koja se obično 
javlja kod novorođenčadi rođene u terminu ili poslije termina izložene perinatalnom stresu. Najčešće nastaje u prvih šest tjedana 
djetetova života, no moguć je i odgođeni nastup bolesti za nekoliko mjeseci. Žensko dojenče staro 6 tjedana primljeno je na naš odjel 
zbog slabog napredovanja, razdražljivosti i povraćanja. Fizikalni pregled otkrio je na unutarnjem dijelu bedara, bokovima, leđima i 
ramenima potkožne infi ltrate koji su bili tvrdi, blago modrosivi i nisu se činili bolnima na dodir. Laboratorijske pretrage pokazale su 
hiperkalcemiju, dok je ultrazvučni pregled tjelesne masti otkrio hiperehogeničnost, dok je ultrazvuk abdomena pokazao nefrokalci-
nozu. Kompjutorizirana tomografi ja otkrila je prisutnost kalcifi kacija u mozgu. Duboka kožna biopsija potvrdila je dijagnozu nekro-
ze potkožnog masnog tkiva. Liječenje je provedeno opterećenjem tekućinom, uz prestanak nadomještanja vitamina D i prehranu s 
niskim sadržajem kalcija. Dijete je dobilo po jednu dozu kalcitonina i pamidronata. Nakon ove terapije razine kalcija vratile su se na 
normalu. Potkožni infi ltrati postupno su se smanjili i omekšali. U većini opisanih slučajeva regresija kožnih promjena očekuje se kroz 
nekoliko mjeseci, često bez ikakvih zaostalih tragova na koži. Povišena razina kalcija u serumu može potrajati još dugo nakon što se 
kožne promjene povuku pa je potrebno stalno praćenje serumskog kalcija i odgovarajuće liječenje u slučaju hiperkalcemije kako bi 
se spriječila metastatska kalcifi kacija.
Ključne riječi: nekroza masnog tkiva; hiperkalcemija; novorođenče
